WO2012160713A8 - Learning and memory improver - Google Patents

Learning and memory improver Download PDF

Info

Publication number
WO2012160713A8
WO2012160713A8 PCT/JP2011/065641 JP2011065641W WO2012160713A8 WO 2012160713 A8 WO2012160713 A8 WO 2012160713A8 JP 2011065641 W JP2011065641 W JP 2011065641W WO 2012160713 A8 WO2012160713 A8 WO 2012160713A8
Authority
WO
WIPO (PCT)
Prior art keywords
learning
memory
agents
present
aims
Prior art date
Application number
PCT/JP2011/065641
Other languages
French (fr)
Other versions
WO2012160713A1 (en
Inventor
Nobuo Tsuruoka
Hiroshi Watanabe
Original Assignee
Suntory Holdings Limited
Cerebos Pacific Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Limited, Cerebos Pacific Limited filed Critical Suntory Holdings Limited
Publication of WO2012160713A1 publication Critical patent/WO2012160713A1/en
Publication of WO2012160713A8 publication Critical patent/WO2012160713A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Abstract

The present invention aims to provide antidementia agents which are free from the problem of side effects and are excellent in safety. The present invention also aims to provide agents for improving learning and memory which are useful for improvement of learning and memory and can be ingested continuously. The present invention provides antidementia agents and agents for improving learning and memory, each comprising a cyclic dipeptide with the 2,5-diketopiperazine structure as an active ingredient.
PCT/JP2011/065641 2011-05-25 2011-07-01 Learning and memory improver WO2012160713A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011117034A JP2012246224A (en) 2011-05-25 2011-05-25 Antidementia agent and learning and memory improver
JP2011-117034 2011-05-25

Publications (2)

Publication Number Publication Date
WO2012160713A1 WO2012160713A1 (en) 2012-11-29
WO2012160713A8 true WO2012160713A8 (en) 2013-10-10

Family

ID=47216811

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2011/065641 WO2012160713A1 (en) 2011-05-25 2011-07-01 Learning and memory improver

Country Status (3)

Country Link
JP (1) JP2012246224A (en)
TW (1) TW201247214A (en)
WO (1) WO2012160713A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6291158B2 (en) 2012-11-21 2018-03-14 サントリーホールディングス株式会社 Nootropics and learning memory improvers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3830096A1 (en) * 1988-09-03 1990-03-15 Hoechst Ag PIPERAZINDIONE WITH PSYCHOTROPER EFFECT
JP4568603B2 (en) * 2002-05-31 2010-10-27 プロテオテック・インコーポレイテッド Compounds, compositions, and methods for treating amyloid disease and synucleinopathies (eg, Alzheimer's disease, type 2 diabetes, and Parkinson's disease)

Also Published As

Publication number Publication date
JP2012246224A (en) 2012-12-13
WO2012160713A1 (en) 2012-11-29
TW201247214A (en) 2012-12-01

Similar Documents

Publication Publication Date Title
GB2488500A (en) Learning motivation improvers
PH12015501115B1 (en) Learning and memory improver
MX2013012542A (en) Amide compound and pharmaceutical application therefor.
WO2013102144A3 (en) Ph20 polypeptide variants, formulations and uses thereof
EP3679785A3 (en) Methods and compositions for integration of an exogenous sequence within the genome of plants
EP3441468A3 (en) Delivery methods and compositions for nuclease-mediated genome engineering
WO2014205317A3 (en) Cyclic peptides as protein targeting agents
WO2013029013A8 (en) Enzyme producing bacillus strains
PH12015500900B1 (en) A stabilized pemetrexed formulation
IT1404931B1 (en) OPHTHALMIC COMPOSITIONS FOR THE ADMINISTRATION OF LIPO-SOLUBLE ACTIVE PRINCIPLES.
MX2013004061A (en) Cyclosporin analogs.
WO2014057362A3 (en) Omega -3 compositions
WO2012116073A3 (en) Amphiphilic dendron-coils, micelles thereof and uses
TW200942530A (en) Pyridine compounds
PH12015502118A1 (en) Pyridin-4-yl derivatives
WO2013006336A3 (en) Methods and compositions useful for treating fitzpatrick type iv, v or vi skin
WO2011156003A3 (en) Peptoid and synthetic oligomers, pharmaceutical compositions and methods of using same
MX363699B (en) Co-micronisation product comprising ulipristal acetate.
WO2012029074A3 (en) Pharmaceutical compositions of linezolid
WO2014133811A3 (en) Compounds from invasive salvinias and methods of using the same
WO2012036414A3 (en) Cosmetic composition comprising a fermented soybean extract fraction as an active ingredient
WO2012160713A8 (en) Learning and memory improver
WO2015108605A3 (en) Microbial production of branched medium chain alcohols, such as 4- methylpentanol
WO2014031982A3 (en) Methods and compositions for treating pain
WO2012103263A3 (en) Compositions and methods for malate and fumarate production

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11866264

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11866264

Country of ref document: EP

Kind code of ref document: A1